Oncogenic signatures comprising of up-regulated genes in primary keratinocytes from RB1 and RBL2 skin specific knockout, genes upregulated upon EED or EZH2 knockdown, MYC overexpression, stimulation with Shh, and genes upregulated by everolimus are found to be correlated with treated BCNS fibroblasts. The gene discussed is EZH2; the disease is nevoid basal cell carcinoma syndrome.